Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00324155 |
|---|---|
| Brief Title: | Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma |
| First Submitted : | May 8, 2006 |
| First Submitted that Met QC Criteria : | May 9, 2006 |
| First Posted : | May 10, 2006 (Estimate) |
| Results First Submitted : | January 22, 2014 |
| Results First Submitted that Met QC Criteria : | January 22, 2014 |
| Results First Posted : | March 10, 2014 (Estimate) |
| Certification/Extension First Submitted : | January 29, 2011 |
| Certification/Extension First Submitted that Met QC Criteria : | June 17, 2011 |
| Certification/Extension First Posted : | June 20, 2011 (Estimate) |
| Last Update Submitted that Met QC Criteria : | October 24, 2014 |
| Last Update Posted : | November 2, 2014 (Estimate) |